Affiliation:
1. Environmental Biomarker Shared Resource, The Cancer Institute of New Jersey, New Brunswick, NJ
2. Environmental and Occupational Health Sciences Institute, University of Medicine and Dentistry of New Jersey–Robert Wood Johnson Medical School (UMDNJ–RWJMS), Piscataway, NJ
3. Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy and the Environmental and Occupational Health Sciences Institute, Rutgers University, Piscataway, NJ
Abstract
Abstract
Background: Determination of nicotine metabolism/pharmacokinetics provides a useful tool for estimating uptake of nicotine and tobacco-related toxicants, for understanding the pharmacologic effects of nicotine and nicotine addiction, and for optimizing nicotine dependency treatment.
Methods: We developed a sensitive method for analysis of nicotine and five major nicotine metabolites, including cotinine, trans-3′-hydroxycotinine, nicotine-N′-oxide, cotinine-N-oxide, and nornicotine, in human urine by liquid chromatography coupled with a TSQ Quantum triple quadrupole tandem mass spectrometer (LC/MS/MS). Urine samples to which deuterium-labeled internal standards had been added were extracted with a simple solid-phase extraction procedure. Anabasine, a minor tobacco alkaloid, was also included.
Results: The quantification limits of the method were 0.1–0.2 μg/L, except for nicotine (1 μg/L). Cotinine-N-oxide, trans-3′-hydroxycotinine, nicotine, and anabasine in urine were almost completely recovered by the solid-phase extraction, whereas the mean extraction recoveries of nicotine-N′-oxide, cotinine, and nornicotine were 51.4%, 78.6%, and 78.8%, respectively. This procedure provided a linearity of three to four orders of magnitude for the target analytes: 0.2–400 μg/L for nicotine-N′-oxide, cotinine-N-oxide, and anabasine; 0.2–4000 μg/L for cotinine, nornicotine, and trans-3′-hydroxycotinine; and 1.0–4000 μg/L for nicotine. The overall interday method imprecision and recovery were 2.5–18% and 92–109%, respectively.
Conclusions: This sensitive LC/MS/MS procedure can be used to determine nicotine metabolism profiles of smokers, people during nicotine replacement therapy, and passively exposed nonsmokers. This method avoids the need for a time-consuming and labor-intensive sample enrichment step and thus allows for high-throughput sample preparation and automation.
Publisher
Oxford University Press (OUP)
Subject
Biochemistry, medical,Clinical Biochemistry